Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endometrial Carcinoma
100%
Tuberous Sclerosis Complex
100%
Mammalian Target of Rapamycin Signaling
100%
Mammalian Target of Rapamycin (mTOR)
76%
Phosphorylation
30%
Liver Kinase B1 (LKB1)
30%
Rapamycin
23%
Tumor
15%
Primary Tumor
15%
Functional Inactivation
15%
Endometrial Carcinoma Cells
15%
Clinical Trials
7%
Therapeutic Target
7%
Tumor Suppressor
7%
AMP-activated Protein Kinase
7%
MTOR Inhibitor
7%
Akt Phosphorylation
7%
Tumor Suppressor Activity
7%
Carcinoma Cell Lines
7%
Loss of Expression
7%
Phosphatase
7%
Phosphatidylinositol 3-kinase Signaling
7%
Tensin Homolog
7%
Endometrial Cells
7%
Rational Therapeutics
7%
Phosphatidylinositol 3-kinase Inhibitor
7%
Wortmannin
7%
Primary Cells
7%
LY294002
7%
Gatekeepers
7%
PTEN Loss
7%
Tumor Signaling Pathways
7%
PTEN-null
7%
Tuberin
7%
Medicine and Dentistry
Mechanistic Target of Rapamycin
100%
Endometrium Carcinoma
100%
Tuberous Sclerosis
100%
Rapamycin
21%
Cell Line
14%
Primary Tumor
14%
Tumor Suppressor Protein
14%
Protein Kinase B
14%
Tumor
14%
Diseases
7%
Clinical Trial
7%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
7%
Kinase Signaling
7%
Carcinoma Cell
7%
Mammalian Target of Rapamycin Inhibitor
7%
Cell Signaling Pathway
7%
Phosphoinositide 3-Kinase
7%
Wortmannin
7%
Phosphoinositide 3-Kinase Inhibitor
7%
Phosphatase
7%
LY294002
7%
Endometrial Carcinoma Cell Line
7%
Tensin
7%
Tuberin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mammalian Target of Rapamycin
100%
Endometrium Carcinoma
100%
Tuberous Sclerosis
100%
Rapamycin
21%
Tumor Suppressor Protein
14%
Primary Tumor
14%
Protein Kinase B
14%
Clinical Trial
7%
Diseases
7%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
7%
Mammalian Target of Rapamycin Inhibitor
7%
Phosphatidylinositol 3 Kinase
7%
Phosphatidylinositol 3 Kinase Inhibitor
7%
Wortmannin
7%
Phosphatase
7%
2 Morpholino 8 Phenylchromone
7%
Tensin
7%
Tuberin
7%